von Willebrand Panel
Test Code
91242
85240, 85246, 85245, 85730
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Clinical Significance
von Willebrand Panel - von Willebrand disease is the most common bleeding disorder. The diagnosis can only be assured by performing a multiplicity of tests to confirm the diagnosis, and to distinguish type 1, type 2, and type 3 disease types which require different treatment programs. It is essential to measure FVIII activity along with vWF Antigen, Functional vWF Activity by Ristocetin Cofactor and measure Multimeric analysis of von Willebrand Protein to characterize intermediate and high weight forms.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Factor VIII Activity, Clotting
von Willebrand Factor Antigen
Ristocetin Cofactor
Partial Thromboplastin Time, Activated
von Willebrand Factor Antigen
Ristocetin Cofactor
Partial Thromboplastin Time, Activated
Methodology
Immunoturbidimetric Assay • Photometric Clot Detection • Photo-Optical Clot Detection • Platelet Agglutination
Reference Range(s)
See individual tests
Alternative Name(s)
von Willebrand Disease (VWD)
Preferred Specimen(s)
3.6 mL platelet-poor plasma collected in 3.2% sodium citrate (light blue-top) tube
Minimum Volume
1.8 mL
Transport Container
Transport tube
Transport Temperature
Frozen
Specimen Stability
- Room temperature: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 14 days
Reject Criteria
Hemolysis • Lipemia
Setup Schedule
3.6 mL platelet-poor plasma collected in 3.2% sodium citrate (light blue-top) tube
1.8 mL
Transport tube
Frozen
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days
Refrigerated: Unacceptable
Frozen: 14 days
Hemolysis • Lipemia